Patent Ductus Arteriosus
A Patent Ductus Arteriosus (PDS) is a very common finding in the preterm neonate. The significance of this finding and the decision to monitor vs. treat vary between NICUs. This presentation provides the basics of PDA physiology, clinical symptoms, and evidence-based treatment strategies. It provides a comparison of medical vs. surgical treatment and compares PDA ligation and trans-catheter closure.
- Discuss signs and symptoms of PDA, their potential significance and physiologic closure in the premature infant.
- Compare and contrast medical and surgical PDA interventions and their associated risks.
Total CE: 1.1
NCC Codes: NNP 2 or 7
NCC Codes: NIC 2 or 7
NCC Codes: LRN 3 or 7
Rx = 0.25
*This presentation was included in the Small Baby Care Specialist® Program
Last updated: November, 2021
Dr. John Patrick Cleary specializes in all aspects of neonatal intensive care at CHOC Children’s neonatal intensive care unit (NICU). Dr. Cleary serves as the NICU Extracorporeal Life Support Program (ECLS) director at CHOC Children’s and is Regional Director of Neonatology for the CHOC Pediatric Subspecialty Faculty. His research interests include team based care, mechanical ventilation, pulmonary hypertension and non-invasive monitoring . He trained in Pediatrics at the University of Massachusetts and received his ECLS training and Neonatology Fellowship at U.C. San Diego. He is board certified in Pediatrics and Neonatal Perinatal Medicine. He is co-creator of an international conference NeoHeart, cardiovascular management of the neonate and is a founding board member of the Neonatal Heart Society.
Dr. Morchi attended medical school at Dartmouth Medical School, completed residency training in pediatrics at Brown University School of Medicine, and conducted her pediatric cardiology and interventional fellowship in Denver, Colorado at the University of Colorado Health Sciences Center. With board certification in pediatrics and pediatric cardiology, Dr. Morchi specializes in interventional cardiology, caring for the most critical and complex cardiac patients in our cardiac cath lab. Dr. Morchi also holds leadership positions with CHOC serving as the Division Chief & Section Chair for Pediatric Cardiology.